These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term efficacy and safety of dichlorphenamide for treatment of primary periodic paralysis. Sansone VA; Johnson NE; Hanna MG; Ciafaloni E; Statland JM; Shieh PB; Cohen F; Griggs RC Muscle Nerve; 2021 Sep; 64(3):342-346. PubMed ID: 34129236 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Dichlorphenamide for Primary Periodic Paralysis in Adolescents Compared With Adults. Ciafaloni E; Cohen F; Griggs R Pediatr Neurol; 2019 Dec; 101():43-46. PubMed ID: 31570296 [TBL] [Abstract][Full Text] [Related]
7. Treatment of "permanent" muscle weakness in familial Hypokalemic Periodic Paralysis. Dalakas MC; Engel WK Muscle Nerve; 1983; 6(3):182-6. PubMed ID: 6855804 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial. LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of paroxysmal hypokalemic paralysis: experience with diclofenamid]. Sander C Monatsschr Kinderheilkd; 1988 Mar; 136(3):149-50. PubMed ID: 3374500 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of familial hypokalemic paralysis with carbon dioxide anhydrase inhibitors]. Kold A Ugeskr Laeger; 1986 Jul; 148(28):1764-5. PubMed ID: 3750476 [No Abstract] [Full Text] [Related]
11. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Wagg A; Wyndaele JJ; Sieber P Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P; Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467 [TBL] [Abstract][Full Text] [Related]
14. Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. Drenth JP; Vonk AG; Simon A; Powell R; van der Meer JW J Pharmacol Exp Ther; 2001 Sep; 298(3):1221-6. PubMed ID: 11504824 [TBL] [Abstract][Full Text] [Related]
15. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474 [TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM; Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503 [TBL] [Abstract][Full Text] [Related]